Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium Extra is an oral magnesium supplement developed by Protina Pharmazeutische GmbH, specifically associated with the Magnesium-Diasporal 400 EXTRA product line. The active ingredient is trimagnesium dicitrate (magnesium citrate), a form of magnesium noted for its high biocompatibility. The supplement is used to maintain magnesium ion (Mg2+) homeostasis, which plays a critical role in vascular smooth muscle relaxation and blood pressure regulation. In clinical research, Magnesium Extra has been evaluated in randomized, double-blind, placebo-controlled trials to determine whether daily oral magnesium supplementation can prevent blood pressure increases and gestational hypertension in healthy first-time pregnant women.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium citrate (Protina Pharmazeutische GmbH).